Send the following on WhatsApp
Continue to ChatHydroxychloroquine is one of several agents being evaluated in the treatment of severe acute respiratory syndrome coronavirus 2. Overall mortality was lower in the hydroxychloroquine group than in the group that did not receive hydroxychloroquine. https://www.umdaa.co/blogs/240/long-term-hydroxychloroquine-use-in-patients-with-rheumatic-conditions-and-development-of-sars-cov-2-infection-a-retrospective-cohort-study